<--- Back to Details
First PageDocument Content
Integrase inhibitors / Gilead Sciences / Cyclopropanes / Carbamates / Antiretroviral drug / Efavirenz / Raltegravir / Fixed-dose combination / Reverse-transcriptase inhibitor / Chemistry / Organic chemistry / Organofluorides
Date: 2015-01-14 06:19:30
Integrase inhibitors
Gilead Sciences
Cyclopropanes
Carbamates
Antiretroviral drug
Efavirenz
Raltegravir
Fixed-dose combination
Reverse-transcriptase inhibitor
Chemistry
Organic chemistry
Organofluorides

Add to Reading List

Source URL: www.england.nhs.uk

Download Document from Source Website

File Size: 132,08 KB

Share Document on Facebook

Similar Documents

Gilead Sciences / Chemistry / HIV/AIDS / Medicine / Organofluorides / Specialty drugs / Prodrugs / Prevention of HIV/AIDS / AIDS Healthcare Foundation / Tenofovir alafenamide / Tenofovir disoproxil / Fixed-dose combination

Case 3:16-cvDocument 1 FiledPage 1 ofDorian S. Berger, CA State Bar NoDaniel P. Hipskind, CA State Bar No

DocID: 1rqYi - View Document

Gilead Sciences / Tenofovir alafenamide / Tenofovir disoproxil / Emtricitabine / Gilead / Fixed-dose combination

GENERAL CONFORMITY CERTIFICATE This is an electronically controlled document. User is responsible for verifying and using the effective version. Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that bas

DocID: 1pCJo - View Document

Gilead Sciences / Tenofovir alafenamide / Tenofovir disoproxil / Emtricitabine / Gilead / Fixed-dose combination

Microsoft Word - GOCER-028.docx

DocID: 1pkag - View Document

Gilead Sciences / Organofluorides / Specialty drugs / Tenofovir alafenamide / Cobicistat / Gilead / Emtricitabine / Tenofovir disoproxil / Elvitegravir / Fixed-dose combination

GENERAL CONFORMITY CERTIFICATE Pursuant to 15 U.S.C. § 2063(a), Gilead Sciences, Inc. certifies that based on a reasonable testing program, the product referenced in this certificate complies with applicable regulations

DocID: 1oSag - View Document

Gilead Sciences / Chemistry / Fixed dose combination / Pharmacology / Organic chemistry / Bristol-Myers Squibb / Non-nucleoside reverse transcriptase inhibitors / Organofluorides / Tenofovir disoproxil / Efavirenz/emtricitabine/tenofovir / Tenofovir/emtricitabine / Fixed-dose combination

BMS_Gilead_Logo_FINAL.eps

DocID: 1m38a - View Document